tazemetostat hydrobromide

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 1467052-75-0

Where It Comes From

2 FDA-registered drug labelers
Epizyme, Inc.
Sterling Pharma Solutions Limited

Why It Matters

Sectors
Health
Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

  • Tazverik
FDA Shortage Status
No Shortage
Shortage History
to be discontinued

Tazemetostat Hydrobromide Tablet

03/27/2026

Vendor Pricing

$342.00/gCombi-Blocks, Inc.
CountryUnited States
Pack$1710.00 / 5 g
Purity95%
Vendors12 available

Prices reflect listed pack sizes. Small research packs run far above bulk rates.

11 more vendors
VendorCountry$/gPackPurity
BLD Pharmatech Ltd.China$350.805 g98%
Ambeed, Inc.United States$385.805 g98%
A2B Chem LLCUnited States$392.001 g99.8%
Angene ChemicalChina Hong Kong$430.405 g98%
Aaron Chemicals LLCHong Kong$536.001 g98%
AA BLOCKSUnited States$676.00500 mg99.8%
MolnovaChina$714.00500 mg99%
AstaTech (2 weeks)United States$757.001 g95%
MedKoo Biosciences, IncUnited States$2050.001 g98%
TargetMol Chemicals EUAustria$5300.00200 mg99.8%
TargetMol ChemicalsChina United States$7060.00100 mg99.8%

Chemical Identity

CAS1467052-75-0
PubChem CID71761627
DTXSIDDTXSID101027715
FormulaC34H45BrN4O4
Mol. Weight653.6 g/mol
SMILESCCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5.Br

Data Sources

717616272026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/tazemetostat hydrobromide/cids/JSON

Archive: data/sources/pubchem_name/tazemetostat hydrobromide.json

CAS 1467052-75-02026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

CAS 1467052-75-02026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json